Spots Global Cancer Trial Database for adenocarcinoma
Every month we try and update this database with for adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | NCT00672009 | Prostatic Disea... Genital Neoplas... Urogenital Neop... Genital Disease... Adenocarcinoma Prostatic Neopl... Neoplasms, Glan... Carcinoma | Ixabepilone | - | Cedars-Sinai Medical Center | |
| A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer | NCT02048384 | Metastatic Panc... | metformin alone... metformin (Arm ... rapamycin (Arm ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | NCT01398306 | Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle... | Blood sampling ... | 18 Years - | University Medical Center Groningen | |
| Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma | NCT01233375 | Metastatic Panc... | CO-1.01 | 18 Years - | Clovis Oncology, Inc. | |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | NCT00183859 | Adenocarcinoma Gastric Cancer | irinotecan | 18 Years - | University of Southern California | |
| Study of Ruxolitinib in Colorectal Cancer Patients | NCT02119676 | CRC (Colorectal... | Ruxolitinib Regorafenib Placebo | 18 Years - | Incyte Corporation | |
| A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | NCT04990037 | Metastatic Panc... | CAN04 FOLFIRINOX | 18 Years - | Cantargia AB | |
| Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | NCT00102544 | Adenocarcinoma Prostate Neopla... Prostate Cancer Renal Cell Carc... Von Hippel Lind... | EM Tracking | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Effect of Vitamin D and Calcium on Genes in the Colon | NCT00298545 | Colorectal Poly... Colorectal Aden... Adenocarcinoma | placebo and Cal... Calcium and Cal... | 48 Years - 72 Years | Rockefeller University | |
| Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies | NCT04361708 | Pancreatic Aden... Gastroesophagea... Adenocarcinoma | Oxaliplatin Docetaxel Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | University of Chicago | |
| Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas | NCT00918853 | Pancreas Adenocarcinoma | resection of ad... | 18 Years - | Institut Paoli-Calmettes | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy | NCT00795184 | Barrett Syndrom... Barrett's Syndr... Barrett's Esoph... Barrett Esophag... Adenocarcinoma | Imaging procedu... HDWLE pCLE | 18 Years - | Mauna Kea Technologies | |
| Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer | NCT01674556 | Pancreatic Aden... | Gemzar | - | Haukeland University Hospital | |
| BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation | NCT00949650 | Carcinoma, Non-... Adenocarcinoma | Pemetrexed BIBW 2992 Cisplatin | 18 Years - | Boehringer Ingelheim | |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | NCT01161186 | Pancreatic Neop... Pancreatic Canc... Adenocarcinoma | nab-paclitaxel,... | 18 Years - | University of California, San Francisco | |
| Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies | NCT01677559 | Adenocarcinoma Pancreatic Neop... | MLN8237 nab-Paclitaxel | 18 Years - | Washington University School of Medicine | |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | NCT01511081 | Non-small-cell ... | SBRT (stereotac... SBPT (stereotac... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays | NCT02407561 | Rectal Adenocar... Anal Adenocarci... Anal Squamous C... | 18 Years - | Castle Biosciences Incorporated | ||
| UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | NCT01037998 | Non-Small-Cell ... | UFUR and Iressa | 18 Years - | Taipei Veterans General Hospital, Taiwan | |
| A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer | NCT04644770 | Prostatic Neopl... Adenocarcinoma | JNJ-69086420 | 18 Years - | Janssen Research & Development, LLC | |
| Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial | NCT01512589 | Esophageal Canc... | Proton Beam The... Intensity Modul... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) | NCT01121393 | Carcinoma, Non-... Adenocarcinoma | Gemcitabine+Cis... BIBW 2992 | 18 Years - | Boehringer Ingelheim | |
| A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT02875340 | Carcinoma, Non-... Adenocarcinoma | VAL401 | 18 Years - | ValiSeek Limited | |
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT01318642 | Adenocarcinoma ... Locally Advance... Unresectable | Gemcitabine AMG 479 Placebo | 18 Years - | Amgen | |
| Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) | NCT00661830 | Adenocarcinoma | Gemcitabine Placebo Sorafenib | 18 Years - | Johannes Gutenberg University Mainz | |
| Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer | NCT01363466 | Stage IB2 Cervi... Stage II Cervic... Adenocarcinoma Squamous Cell C... Adenosquamous C... | hysterectomy | 18 Years - 70 Years | UNICANCER | |
| A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer | NCT00887536 | Breast Cancer | bevacizumab docetaxel doxorubicin cyclophosphamid... pegfilgrastim | 18 Years - 70 Years | NSABP Foundation Inc | |
| The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase | NCT02755337 | Non-Small-Cell ... | 16 Years - 70 Years | Dr. Soetomo General Hospital | ||
| Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas | NCT01253525 | Adenocarcinoma | Ramucirumab (IM... Paclitaxel | 20 Years - | Eli Lilly and Company | |
| Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) | NCT03415854 | Pancreatic Canc... Pancreatic Duct... Pancreatic Aden... Pancreas Metast... Adenocarcinoma | Paricalcitol (Z... | 18 Years - | HonorHealth Research Institute | |
| Intravenous Iron: Measuring Response in Anemic Surgical Patients | NCT02057471 | Colorectal Neop... Anemia | Intravenous fer... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer | NCT01616303 | Ovarian Neoplas... | Carboplatin Paclitaxel oregovomab | 18 Years - 75 Years | Quest PharmaTech Inc. | |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | NCT01383538 | Pancreatic Canc... Adenocarcinoma Pancreatic Neop... | FOLFIRINOX, IPI... | 18 Years - | University of California, San Francisco | |
| Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer | NCT02404506 | Breast Cancer Adenocarcinoma | Eribulin mesila... | 70 Years - | Swiss Group for Clinical Cancer Research | |
| A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT02875340 | Carcinoma, Non-... Adenocarcinoma | VAL401 | 18 Years - | ValiSeek Limited | |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | NCT03963739 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage III Prost... | Interview Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma | NCT03840967 | Esophageal Canc... Gastric Cancer Adenocarcinoma | Niraparib | 18 Years - | Hoosier Cancer Research Network | |
| A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma | NCT03840967 | Esophageal Canc... Gastric Cancer Adenocarcinoma | Niraparib | 18 Years - | Hoosier Cancer Research Network | |
| Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) | NCT04379596 | Gastric Cancer | Fluorouracil (5... Capecitabine Durvalumab Oxaliplatin Trastuzumab Trastuzumab der... Cisplatin Pembrolizumab Volrustomig Rilvegostomig | 18 Years - 130 Years | AstraZeneca | |
| Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer | NCT00669370 | Stomach Neoplas... | docetaxel and c... | 18 Years - | University of Turku | |
| A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma | NCT01660711 | Pancreatic Aden... | 5 Fluorouracil Leucovorin Irinotecan Oxaliplatin | 18 Years - | NorthShore University HealthSystem | |
| Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | NCT00242918 | Prostate Cancer | docetaxel ZD1839 | 18 Years - | Benaroya Research Institute | |
| Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer | NCT01607905 | Solid Tumor | Selinexor Acetaminophen | 18 Years - | Karyopharm Therapeutics Inc | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer | NCT05014776 | Pancreatic Canc... | Tadalafil Pembrolizumab Ipilimumab CRS-207 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer | NCT00215644 | Esophageal Canc... Gastric Cancer | Matuzumab Epirubicin Cisplatin Capecitabine | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer | NCT04087889 | Pancreatic Canc... | HB-adMSCs | - | Hope Biosciences | |
| Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology | NCT03462524 | Esophageal Canc... Radiation Pneum... Pulmonary Fibro... Respiratory Fai... Pneumonia Surgery Chemotherapy Ef... Radiation Fibro... Radiation Toxic... Adenocarcinoma Squamous Cell C... | Esophagectomy | 18 Years - | St. James's Hospital, Ireland | |
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | NCT00127036 | Adenocarcinoma Colon Cancer | XELOX XELIRI Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Endoscopic Detection of Dysplasia in Crohn 's Disease Patient | NCT01180452 | Crohn Disease L... | enteroscopy | 18 Years - | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | |
| THIO Sequenced With Cemiplimab in Advanced NSCLC | NCT05208944 | Carcinoma, Non-... | 6-Thio-2'-Deoxy... Cemiplimab | 18 Years - | Maia Biotechnology | |
| Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer | NCT01637376 | Carcinoma, Non-... | Temoporfin | 18 Years - | University of Arkansas | |
| SERum-bank for PANcreatic Cancer | NCT04374175 | Adenocarcinoma | Blood sample | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Focal Prostate Radio-Frequency Ablation | NCT02328807 | Prostate Cancer | Radio-Frequency... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | NCT03653507 | Locally Advance... Locally Advance... Metastatic Gast... Metastatic Gast... | zolbetuximab oxaliplatin capecitabine placebo | 18 Years - | Astellas Pharma Inc | |
| HS-PCI in Locally Advanced Adenocarcinoma of the Lung | NCT02341170 | Lung Cancer Adenocarcinoma Lymphatic Metas... | HS-PCI | 18 Years - 75 Years | Universitätsmedizin Mannheim | |
| Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | NCT01472029 | Adenocarcinoma ... Adenocarcinoma ... | 5-FU, leucovori... Post-operative ... | 18 Years - | AIO-Studien-gGmbH | |
| Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI | NCT01020630 | Adenocarcinoma | Sunitinib Placebo | 18 Years - | Johannes Gutenberg University Mainz | |
| Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma | NCT01565538 | Lung Cancer | Erlotinib Pemetrexed | 18 Years - 75 Years | Sun Yat-sen University | |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| Immunochemoradiotherapy in Patients With Pancreatic Cancer | NCT01342224 | Locally Advance... | tadalafil and v... | 18 Years - | Providence Health & Services | |
| Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer | NCT00892242 | Adenocarcinoma | Zoledronic acid | 18 Years - | Washington University School of Medicine | |
| Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma | NCT02863471 | Adenocarcinomas... | Gemcitabine | 18 Years - 100 Years | University Hospital Tuebingen | |
| Trimodality Management of T1b Esophageal Cancers | NCT01217060 | Esophageal Canc... | Docetaxel 5-FU Radiotherapy Esophagectomy Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas | NCT00377936 | Adenocarcinoma Metastasis Pancreas Neopla... | Gemcitabine alo... EndoTAG-1 and G... EndoTAG-1 and G... EndoTAG-1 and G... | 18 Years - | MediGene | |
| Effect of Zinc on Barrett's Metaplasia | NCT01984580 | Barrett's Metap... | zinc gluconate | 18 Years - 80 Years | Main Line Health | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Treatment of Multifocal Lung Adenocarcinoma | NCT01946100 | Lung Neoplasms Carcinoma Non-s... Adenocarcinoma | Multifocal Lung... | 18 Years - | Mayo Clinic | |
| Effect of Zinc on Barrett's Metaplasia | NCT01984580 | Barrett's Metap... | zinc gluconate | 18 Years - 80 Years | Main Line Health | |
| Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors | NCT00106353 | Adenocarcinoma Neoplasms | Torisel | 1 Year - 21 Years | Pfizer | |
| Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer | NCT04669951 | Esophagus Cance... | uPAR immunohist... | 18 Years - | Rigshospitalet, Denmark | |
| Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | NCT00402025 | Pancreatic Canc... | Talimogene Lahe... | 18 Years - | BioVex Limited | |
| Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma | NCT04069273 | Gastric Cancer GastroEsophagea... Adenocarcinoma | Pembrolizumab M... Ramucirumab Paclitaxel | 18 Years - | Hoosier Cancer Research Network | |
| Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer | NCT02342626 | Adenocarcinoma ... | Dashboard | 40 Years - 85 Years | University of Rochester | |
| Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | NCT01665417 | EGFR Positive N... Adenocarcinoma | Experimental Chemotherapy Chemotherapy | 18 Years - 70 Years | Betta Pharmaceuticals Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
